Congenital diaphragmatic hernia and associated cardiovascular malformations: type, frequency, and impact on

Angela E Lin1, Barbara R Pober, Ian Adatia

  • 1Genetics Unit, MassGeneral Hospital for Children, Boston, MA 02114, USA. lin.angela@mgh.harvard.edu

Insights

Congenital diaphragmatic hernia (CDH) often co-occurs with cardiovascular malformations (CVMs), impacting patient prognosis. Studies should differentiate isolated CDH from syndromic cases for accurate CVM assessment and tailored therapies.

Area of Science:

  • Pediatric Surgery
  • Cardiology
  • Developmental Biology

Background:

  • Congenital diaphragmatic hernia (CDH) and cardiovascular malformations (CVMs) frequently co-occur, presenting complex clinical challenges.
  • Previous studies often included patients with genetic syndromes, potentially biasing findings on the CDH-CVM relationship.

Purpose of the Study:

  • To accurately determine the frequency of CVMs in isolated CDH.
  • To analyze the types of CVMs associated with isolated CDH.
  • To clarify the prognostic implications of combined CDH and CVMs, distinguishing syndromic cases.

Main Methods:

  • Extensive literature review to identify studies focusing on isolated CDH.
  • Analysis of new data to assess the co-occurrence and types of CVMs.
  • Evaluation of prognostic factors, including pulmonary hypoplasia and vascular disease.

Main Results:

  • Cardiovascular malformations (CVMs) occur in 11-15% of isolated congenital diaphragmatic hernia (CDH) cases.
  • Atrial/ventricular septal defects and outflow tract defects are common CVMs in CDH patients.
  • Pulmonary hypoplasia and vascular disease significantly predict outcomes in CDH patients with CVMs.

Conclusions:

  • The combination of CDH and CVMs worsens prognosis compared to either condition alone.
  • Future research must differentiate isolated CDH from syndromic cases for precise CVM analysis.
  • Therapeutic strategies should prioritize cardiac output and oxygen delivery over saturation alone.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...